Bemiparin sodium
Bemiparin is an antithrombotic and belongs to the group of low molecular weight heparins (LMWH).[1]
Like semuloparin, bemiparin is classified as an ultra-LMWH because of its low molecular mass of 3600 Daltons on average.[2] (Enoxaparin has 4500 Daltons.) These heparins have lower anti-thrombin activity than classical LMWHs and act mainly on factor Xa, reducing the risk of bleeding.[3]
References
- ↑ Chapman TM, Goa KL (2003). "Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis". Drugs 63 (21): 2357–77. doi:10.2165/00003495-200363210-00009. PMID 14524738.
- ↑ Planès, A. (2003). "Review of bemiparin sodium – a new second-generation low molecular weight heparinand its applications in venous thromboembolism". Expert Opinion on Pharmacotherapy 4 (9): 1551–1561. doi:10.1517/14656566.4.9.1551. PMID 12943485.
- ↑ Jeske, W. P.; Hoppensteadt, D.; Gray, A.; Walenga, J. M.; Cunanan, J.; Myers, L.; Fareed, J.; Bayol, A.; Rigal, H. L. N.; Viskov, C. (2011). "A common standard is inappropriate for determining the potency of ultra low molecular weight heparins such as semuloparin and bemiparin". Thrombosis Research 128 (4): 361–367. doi:10.1016/j.thromres.2011.03.001. PMID 21458847.
|
---|
| Antiplatelet drugs | | |
---|
| | |
---|
| | |
---|
| | |
---|
| Thromboxane inhibitors |
- Thromboxane synthase inhibitors
- Receptor antagonists
|
---|
| | |
---|
| Other | |
---|
|
---|
| Anticoagulants | | |
---|
| Factor Xa inhibitors (with some II inhibition) | |
---|
| | |
---|
| Other | |
---|
|
---|
| Thrombolytic drugs/ fibrinolytics | |
---|
| Non-medicinal | |
---|
| |
---|
| Description |
- Immune system
- Cells
- Physiology
- coagulation
- proteins
- granule contents
- colony-stimulating
- heme and porphyrin
|
---|
| Disease |
- Red blood cell
- Monocyte and granulocyte
- Neoplasms and cancer
- Histiocytosis
- Symptoms and signs
- Blood tests
|
---|
| Treatment |
- Transfusion
- Drugs
- thrombosis
- bleeding
- other
|
---|
|
|